Biogen stock touches 52-week low at $144.96 amid challenges By Investing.com

Biogen Idec Inc (NASDAQ:)’s stock has faced significant headwinds, touching a 52-week low of $144.96. The biotechnology firm, known for its innovative therapies for neurological diseases and commanding a market capitalization of $21.2 billion, has seen its shares tumble amidst a challenging market environment and internal pressures. According to InvestingPro analysis, the company maintains a…

Read Full News